Ophthalmic manifestation of leukemia

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

This paper includes a literature review on the ophthalmic manifestations of leukemia. Various eye disorder types in leukemia with concurrent anemia, hypoxia, increased blood viscosity, as well as the compression of tissues by tumor cells conglomerates and/or presence of direct leukemic infiltration were considered. Ophthalmic diseases in patients with hematological malignancies may occur due to opportunistic infections and the impact of such treatments as chemotherapy, radiotherapy and bone marrow transplantation. Reliable estimation of eye involvement rates in leukemic process is difficult, as many patients are asymptomatic at early stages of the disease. However, the predictive value of visual impairment assessment in leukemia is high, which requires close cooperation between ophthalmologists and hematologists, and appropriate adjustment of both local and systemic therapies.

Full Text

Restricted Access

About the authors

Natalia V Chistyakova

Scientific Research Institution of Pediatric Oncology, Hematology and Transplantology n.a. R.M. Gorbacheva

MD, ophthalmologist

References

  1. Астахов С.Ю., Ткаченко Н.В., Чистякова Н.В. Опыт применения препарата Растасис® у пациентов с синдромом «сухого глаза», протекающим на фоне реакции трансплантат против хозяина после аллогенной трансплантации костного мозга // Офтальмологические ведомости. - 2015. - Т. 8. - № 2. - С. 58-70. [Astakhov SY, Tkachenko NV, Chistyakova NV. Opyt primeneniya preparata Rastasis® u patsientov s sindromom “sukhogo glaza”, protekayushchim na fone reaktsii transplantat protiv khozyaina posle allogennoi transplantatsii kostnogo mozga. Oftal’mologicheskie vedomosti. 2015;8(2):58-70. (in Russ).]
  2. Бржеский В.В., Майчук Д.Ю. Новые возможности иммуносупрессивной терапии у больных с синдромом «сухого глаза». - 2012. - Т. 5. - № 1. - С. 69-74. [Brzheskii VV, Maichuk DY. Novye vozmozhnosti immunosupressivnoi terapii u bol’nykh s sindromom “sukhogo glaza”. 2012; 5(1):69-74. (in Russ).]
  3. Габдрахманова А.Ф., Лукманов С.Р., Александров А.А. Клинический случай поражения органа зрения при лейкозе. II Междисциплинарный конгресс по заболеваниям органов головы и шеи. Москва 27-29 мая 2014. [Gabdrakhmanova AF, Lukmanov SR, Aleksandrov AA. Klinicheskii sluchai porazheniya organa zreniya pri leikoze. II Mezhdistsiplinarnyi kongress po zabolevaniyam organov golovy i shei. Moscow 27-29; May 2014. (in Russ).]
  4. Al-Rashid RA, Cress C. Mumps uveitis complicating the course of leukaemia. J Pediatr Ophthalmol.1977;14:100-102.
  5. Albert DM, Wong VG, Henderson ES. Ocular complications of vincristine therapy. Arch Ophthalmol. 1967;78:709-713. doi: 10.1001/archopht.1967.00980030711004.
  6. Alemayehu W, Shamebo M, Bedri A, Mengistu Z. Ocular manifestations of leukaemia in Ethiopians. Ethiop Med J. 1996;34:217-224.
  7. Allen RA, Straatsma BR. Ocular involvement in leukaemia and allied disorders. Arch Ophthalmol. 1961;66:490-508. doi: 10.1001/archopht.1961.00960010492010.
  8. Antunes NL, Small TN, George D, Boulad F, Lis E. Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol. 1999;20:241-243. doi: 10.1016/S0887-8994(98)00148-9.
  9. Аragona P,Tripodi G, Spinella R, et al. The effects of the topical administration of non-steroidal anti-inflammatory drugs on corneal epithelium and corneal sensitivity in normal subjects. Eye (Lond). 2000;14(Pt 2):206-210.
  10. Ayliffe W, Foster CS, Marcoux P, et al. Relapsing acute myeloid leukaemia manifesting as hypopyon uveitis. Am J Ophthalmol. 1995;119:361-364.
  11. Ballantyne AJ, Michaelson IC.Textbook of the Fundus of the Eye. Williams and Wilkins: Baltimore, 1970:290-292.
  12. Bhadresa GN. Changes in the anterior segment as a presenting feature in leukaemia. Br J Ophthalmol. 1971;55:133-135. doi: 10.1136/bjo.55.2.133.
  13. Brown GC, Shields JA, Augsburger JJ, at al. Leukemic optic neuropathy. Int Ophthalmol. 1981;3:111-116. doi: 10.1007/BF00133423.
  14. Burns CA, Blodi FC, Williamson BK. Acute lymphocytic leukaemia and central serous retinopathy. Trans Am Acad Ophthalmol Otolaryngol. 1965;69:307-309.
  15. Carta A, Cesana C. Ocular presentation and successful outcome of invasive sphenoid sinus aspergillosis in acute myelogenous leukaemia. Haematologica. 1998;83:1116-1119.
  16. Cavdar AO, Gozdasoglu S, Arcasoy A, Demirag B. Chloroma-like ocular manifestations in Turkish children with acute myelo-monocytic leukaemia. Lancet. 1971;1:680-682.
  17. Chiang CC, Lin JM, Chen WL, et al. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Cornea. 2007;26(7):P.861-3. doi: 10.1097/ICO.0b013e3180645cd7.
  18. Cogan DG. Immunosuppression and eye disease. Am J Ophthalmol. 1977;83:777-788. doi: 10.1016/0002-9394(77)90903-5.
  19. Cook BEJ, Bartley GB. Acute lymphoblastic leukaemia manifesting in an adult as a conjunctival mass. Am J Ophthalmol. 1997; 124:104-105. doi: 10.1016/S0002-9394(14)71651-4.
  20. Colón-Acevedo B, Rivera-Román L, Candelario N, et al. Ocular manifestations of acute graft versus host disease after allogeneic bone marrow transplant. BolAsoc Med P R. 2014;106(2):30-32.
  21. Colombini A, Barzaghi A, Castagneto M, Bovo G, Rossi MR, Rovelli A, et al. Retro-orbital late relapse in a child with leukaemia after allogeneic bone marrow transplantation. Acta Haematol. 1995; 94:44-47. doi: 10.1159/000203970.
  22. Claes K, Kestelyn P. Ocular manifestations of graft versus host disease following bone marrow transplantation. Bull Soc Belge Ophtalmol. 2000;77:21-26.
  23. Cullis CM, Hines DR, Bullock JD. Anterior segment ischaemia: classification and description in chronic myeloid leukaemia. Ann Ophthalmol. 1979;11:1739-1744.
  24. Curto Mlo, Zingone A, Aquaviva A, Bagnulo S, Calculli L, Cristiani L et al. Leukaemic infiltration of the eye: results of therapy in a retrospective multicentric study. Med Pediatr Oncol. 1989;17: 134-139. doi: 10.1002/mpo.2950170212.
  25. Dastjerdi MH, Hamrah P, Dana R. High-frequency topical cyclosporine 0.05 % in the treatment of severe dry eye refractory to twice-daily regimen. Cornea. 2009;28(10):1091-6. doi: 10.1097/ICO.0b013e3181a16472.
  26. Dawson DM, Rosenthal DS, Moloney WC. Neurologic complications of acute leukaemia in adults: changing rates. Ann Int Med. 1973;79:541-4. doi: 10.7326/0003-4819-79-4-541.
  27. Devec H,Kobak S.The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren’s syndrome. Int Ophthalmol. 2014;34(5):1043-8. doi: 10.1007/s10792-014-9901-4.
  28. Duke-Elder S. System of ophthalmology. Cornea and conjunctiva. CV Mosby: St Louis, 1965:1190-1195.
  29. Ellis W, Little HL. Leukaemic infiltration of the optic nerve head. Am J Ophthalmol. 1973;75:867-871. doi: 10.1016/0002-9394(73)90893-3.
  30. Esmaeli B, Medeiros LJ, Myers J, et al. Orbital mass secondary to precursor T-cell acute lymphoblastic leukemia: a rare presentation. Arch Ophthalmol. 2001;119: 443-6. doi: 10.1001/archopht.119.3.443.
  31. Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945-56. doi: 10.1016/j.bbmt.2005.09.004.
  32. Fonken HA, Ellis PP. Leukaemic infiltrates in the iris. Arch Ophthalmol. 1966;76:32-6. doi: 10.1001/archopht.1966. 03850010034009.
  33. Frank RN, Ryan SJ. Peripheral retinal neovascularistation with chronic myelogenous leukaemia. Arch Ophthalmol. 1972;87(5): 585-9. doi: 10.1001/archopht.1972.01000020587017.
  34. Frisk P, Hagberg H, Mandahl A, Soderberg P, Lonnerholme G. Cataract in children after autologous bone marrow transplantation. A common but curable complication. Lakartidningen. 2002; 99:1444-7.
  35. Garrido Colino C, Mateos Gonzalez M, Torres Valdivieso M, et al. Ocular infiltration in the anterior chamber in a female infant with acute non-lymphoblastic leukaemia. Anales Espanoles de Pediatria. 2001; 55: 69-72. doi: 10.1016/S1695-4033(01)77629-1.
  36. Gass JDM. Differential Diagnosis of Intraocular Tumours: A Stereoscopic Presentation. CV Mosby: St Louis, 1974, pp 160-176.
  37. Giagounidis AA, Meckenstock G, Flacke S, et al. Pseudamonas aeruginosa blepharoconjunctivitis during cytoreductive chemotherapy in a woman with acute lymphocytic leukaemia. Ann Hematol. 1997;75:121-3. doi: 10.1007/s002770050325.
  38. Gupta C, Chauhan A. Ophthalmic delivery of cyclosporine A by punctal plugs. J Control Release. 2011;150(1):70-6. doi: 10.1016/j.jconrel.2010.11.009.
  39. Hopen G, Mondino BJ, Johnson BL, Chervenick PA. Corneal toxicity with systemic cytarabine. Am J Ophthalmol. 1981;91:500-4. doi: 10.1016/0002-9394(81)90240-3.
  40. Hine JE, KIngham JD. Myelogenous leukaemia and bilateral exudative retinal detachment. Ann Ophthalmol. 1979; 11: 1867-72.
  41. Hsu LY, Jou JR, Tseng HS, Shiue C, Hou PK, Lin KH. Relapse of acute leukemia in childhood presenting as proptosis due to an orbital mass. J Formos Med Assoc. 1997;96:835-8.
  42. Hyman CB, Bogle JM, Brubaker CA, et al. Central nervous system involvement by leukaemia in children. Blood. 1965;25:1-12.
  43. Jabs DA, Hirst LW, Green WR, et al. The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol. 1983;101: 585-90. doi: 10.1001/archopht.1983.01040010585011.
  44. Jabs DA,Wingard J, Green WR, et al.The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol. 1989;107(9):1343-8. doi: 10.1001/archopht.1989.01070020413046.
  45. Jacobs R, Tran U, Chen H, et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant. 2012;47(11):1470-3. doi: 10.1038/bmt.2012.56.
  46. Jakobiec FA, Jones IS. Lymphomatous plasmacytic, histiocytic, haematopoietic tumours. In: Jones IS, Jakobiec FA (eds). Diseases of the Orbit. Hagerstown Md, Harper and Row. 1979. P. 309.
  47. Jampol LM, Goldberg MF, Busse B. Peripheral retinal micro aneurysms in chronic leukaemia. Am J Ophthalmol. 1975;80:242-8. doi: 10.1016/0002-9394(75)90139-7.
  48. Jankovic M, Conter V, Pretto G, Placa F, D’Incalci M, Masera G. Isolated bilateral anterior chamber eye relapse in a child with acute lymphoblastic leukaemia. Med Pediatr Oncol. 1995;25(2): 109-12. doi: 10.1002/mpo.2950250211.
  49. Jung JW, Lee YJ, Yoon SC, et al. Long-term result of maintenance treatment with tacrolimus ointment in chronic oculargraft-versus-host disease. Am J Ophthalmol. 2015;159(3):519-27. doi: 10.1016/j.ajo.2014.11.035.
  50. Kajimoto H, Naya M, Hojo M, Hibi S, Imashuku S. Relapse of acute lymphoblastic leukaemia as a retro-orbital mass (review). Jpn J Clin Hematol. 1999; 40: 1193-1197.
  51. Kasmann B, Ruprecht KW. Ophthalmologic findings in graft versus host disease (GvHD). Klin Monatsbl Augenheilkd. 1993;202: 491-9. doi: 10.1055/s-2008-1045634.
  52. Karesh JW, Goldman EJ, Reck K, et al. A prospective ophthalmic evaluation of patients with acute myeloid leukemia: correlation of ocular and hematologic findings. Journal of Clinical Oncology. Oct 1989;7(10):1528-32.
  53. Kiang E,Tesavibul N, Yee R, et al. The use of topical cyclosporin A in ocular graft-versus-host-disease. Bone Marrow Transplant. 1998;22(2):147-51. doi: 10.1038/sj.bmt.1701304.
  54. Kim SK. Update on ocular graft versus host disease. Curr Opin Ophthalmol. 2006;17(4):344-8. doi: 10.1097/01.icu.0000233952.09595.d8.
  55. Kincaid MC, Green WR. Ocular and orbital involvement in Leukaemia. Surv Ophthalmol. 1983; 27(4): 211-232. doi: 10.1016/0039-6257(83)90123-6.
  56. Kiratli H. Isolated extraocular muscles involvement as the ophthalmic manifestation of leukemia. Clinical & Experimental Ophthalmology. 2009;37(6):609-613. doi: 10.1111/j.1442-9071.2009.02099.x.
  57. Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol. 2002;120 (3):330-7. doi: 10.1001/archopht.120.3.330.
  58. Kunert KS,Tisdale AS, Stern ME, et al. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol. 2000;118 (11):1489-96. doi: 10.1001/archopht.118.11.1489.
  59. Kuwabara T, Aiello L. Leukaemic military nodule in retina. Arch Ophthalmol. 1964;72:494-7. doi: 10.1001/archopht. 1964.00970020494010.
  60. Lakhkar BN, Banavali S, Philip P. Orbital granulocytic sarcoma in acute myelogenous leukaemia. Indian J Pediatr. 2000;67:234-5.
  61. Lei KI, Liew CT, Lam DS, Chan AT, Wickham NW. Acute monoblastic leukaemia with conjunctival tumours. Clint Once (R Cull Radial). 1995;7:405-6. doi: 10.1016/S0936-6555(05)80018-4.
  62. Lever WF. Schaumburg. Histopathology of skin. 5th ed. JB, Lippincott: Philadelphia; 1975, pp 705-707.
  63. Luschmann C, Tessmar J, Schoeberl S, et al. Self-assembling colloidal system for the ocular administration of cyclosporine A. Cornea. 2014;33(1):77-81. doi: 10.1097/ICO.0b013e3182a7f3bf.
  64. Macintyre E, Flandrin G. Biological classification of acute leukemias: federalization or centralization? Leukemia. 1995;9:2152-4.
  65. MacLean H, Clarke MP, Strong NP, Kernahan J. Primary relapse of acute leukaemia in anterior segment of the eye. Lancet. 1995;346:500. doi: 10.1016/S0140-6736(95)91347-5.
  66. Marsh P, Pflugfelder SC. Topical nonpreserved methylpresdnisolone therapy of keratoconjunctivits sicca in sjogren’s syndrome. Ophthalmology. 1999;106:811-6. doi: 10.1016/S0161-6420(99)90171-9.
  67. Martin B. Infiltration of the iris in chronic lymphatic leukaemia. Br J Ophthalmol. 1968; 52:781-5. doi: 10.1136/bjo.52.10.781.
  68. Masera G, Carnelli V, Uderzo C, et al. Ocular involvement in leukaemia: Report of three cases. Lancet. 1977;1:829-31.
  69. Mausolf FA, Mensher JH. Experimental hyperviscosityretinopathy: preliminary report. Ann Ophthalmol. 1973;5:205-9.
  70. McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: benefits and risks. Drug Saf. 2002;25:33-55. doi: 10.2165/00002018-200225010-00004.
  71. Meredith TA, Aaberg TM, Reeser FH. Rhegmatogenous retinal detachment complicating CMV retinitis. Am J Ophthalmol. 1979; 87:793-6. doi: 10.1016/0002-9394(79)90356-8.
  72. Mixon B, Mixon J, Isbey EK, et al. Autologous serum eye drops for severe dry eye syndrome in a patient with chronic graft-versus-host disease: a case report. Int J Pharm Compd. 2014;18(5):370-7.
  73. Mondino BJ, Brown SI, Mondzelewski JP. Peripheral corneal ulcers with herpes zoster ophthalmicus. Am J Ophthalmol. 1978; 86:611-4. doi: 10.1016/0002-9394(78)90176-9.
  74. Morgan KW, Callen JP. Sweet’s syndrome in acute myelogenous leukaemia presenting as periorbital cellulitis with an infiltrate of leukemic cells. J Am Acad Dermatol. 2001;45:590-5. doi: 10.1067/mjd.2001.119032
  75. Murray KH, Paolino F, Goldman JM, Galton DA, Grindle CF. Optic nerve head infiltration in acute leukemia in children: an indication for emergency optic nerve radiation therapy. Med Pediatr Oncol. 1996;26:101-4. doi: 10.1002/(SICI)1096-911X(199602)26:2<101::AID-MPO6>3.0.CO;2-P.
  76. Nerkelun S, Kellermann S, Nenning H. Acute blindness caused by fungal infection in chronic myeloid leukaemia. Klin Manatslbl Augenhertkd. 1997;211:272-4. doi: 10.1055/s-2008-1035134.
  77. Newman NM, Smith ME, Gay AJ. An unusual case of leukaemia involving the eye: a clinico-pathological study. Surv Ophthalmol. 1972;16:316-21.
  78. Ng JS, Lam DS, Li CK, et al. Ocular complications of pediatric bone marrow transplantation. Ophthalmology. 1999;106:160-4. doi: 10.1016/S0161-6420(99)90023-4.
  79. Ninane J, Taylor D, Day S. Leukaemic hypopyon in acute lymphoblastic leukaemia after interruption of treatment. Arch Dis Child. 1979;54:73-4. doi: 10.1136/adc.54.1.73.
  80. Ohkoshi K, Tsiaras WG. Prognostic importance of ophthalmic manifestations in childhood leukaemia. Br J Ophthalmol. 1992;76:651-5. doi: 10.1136/bjo.76.11.651.
  81. Ogawa Y, Kim SK, Dana R, et al. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep. 2013;3: 3419. doi: 10.1038/srep03419.
  82. O’Rourke JF, O’Connor GR. Unusual ocular involvement in acute leukaemia. Arch Ophthalmol. 1957;57:585-9. doi: 10.1001/archopht.1957.00930050597013.
  83. O’Rourke JF, O’Connor GR. The eye as a sanctuary in acute lymphoblastic leukaemia. Lancet. 1980;1:452-3.
  84. Perry HD, Mallen FJ. Iris involvement in granulocytic sarcoma. Am J Ophthalmol. 1979;87:530-2. doi: 10.1016/0002-9394(79)90243-5.
  85. Pflugfelder SC, Maskin SL, Anderson B, et al. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5 %, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138:444-57. doi: 10.1016/j.ajo.2004.04.052.
  86. Primack JD, Smith ME, Tychsen L, et al. Retinal detachment in a child as the first sign of leukemic relapse. J Pediatr Ophthalmol Strabismus. 1995;32:253-6.
  87. Ravindranathan MP, Paul VJ, Kuriakose ET. Cataract after busulphan treatment. Br Med J. 1972;1:218-9. doi: 10.1136/bmj.1.5794.218.
  88. Reddy SC, Menon BS. A prospective study of ocular manifestations in childhood acute leukaemia. Acta Ophthalmol Scand. 1998;76:700-3. doi: 10.1034/j.1600-0420.1998.760614.x.
  89. Reese AB, Guy L. Exophthalmos in leukaemia. Am J Ophthalmol. 1933;16:718-20. doi: 10.1016/S0002-9394(33)93848-9.
  90. Ridgway EW, Jaffe N, Walton DS. Leukemic ophthalmopathy in children. Cancer. 1976;38:1744-46. doi: 10.1002/1097-0142(197610)38:4<1744::AID-CNCR28203 80449>3.0.CO;2-3.
  91. Roberts CW, Carniglia PE, Brazzo BG. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye. Cornea. 2007;26(7):805-9. doi: 10.1097/ICO.0b013e318074e460.
  92. Rosenthal AR, Egbert PR, Wilbur JR, Probert JC. Leukemic involvement of optic nerve. J Ped Ophthalmol. 1975;12: 84-93.
  93. Rowan PJ, Sloan JB. Iris and Anterior chamber involvement in leukaemia. Ann Ophthalmol. 1976;8:1081-5.
  94. Russo V, Scott IU, Querques G, et all. Orbital and ocular manifestation of acute childhood leukemia: clinical and statistical analysis of 180 patients. Eur J Ophthalmol. 2008;18(4):619-623.
  95. Sall K, Stevenson OD, Mundorf TK, et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology. 2000;107(4):631-9. doi: 10.1016/S0161-6420(99)00176-1.
  96. Schworm HD, Nasemann JE, Schriever S. Subretinal hypopyon in prolymphocytic leukaemia. Br J Ophthalmol. 1995;79:863-4. doi: 10.1136/bjo.79.9.863.
  97. Shaw RK, Moore EW, Freireich EJ, Thomas LB. Meningeal leukaemia. Neurology. 1960;10:823-33. doi: 10.1212/WNL.10.9.823.
  98. Shibata K, Shimamoto Y, Nishimura T, Okinami S, Yamada H, Miyahara M. Ocular manifestation in adult T cell leukaemia/lymphoma. Ann Hematol. 1997;74:163-8. doi: 10.1007/s002770050276.
  99. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft vs host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57:267-76.
  100. Shurin SB, Rekate HL, Annable W. Optic atrophy induced by vincristine. Pediatrics. 1982;70:288-91.
  101. Sosne G, Dunn SP, Kim C. Thymosin β4 Significantly Improves Signs and Symptoms of Severe Dry Eye in a Phase 2 Randomized Trial. Cornea. 2015;34(5):491-6. doi: 10.1097/ICO.0000000000000379.
  102. Soylu M, Ozdemir G, Anli A. Pediatric uveitis in southern Turkey. Ocul Immunol Inflamm. 1997;5:197-202. doi: 10.3109/ 09273949709116894.
  103. Spraul CW, Lang GE, Lang GK. Corneal ulcer in chronic graft-versus-host disease: treatment with collagen shields. Klin Monatsbl Augenheilkd. 1994;205:161-6. doi: 10.1055/s-2008-1045510.
  104. Stentoft J. The toxicity of cytarabine. Drug Saf. 1990;5:7-27. doi: 10.2165/00002018-199005010-00003.
  105. Su MY, Perry HD, Barsam A, et al. The effect of decreasing the dosage of cyclosporine A 0.05 % on dry eye disease after 1 year of twice-daily therapy. Cornea. 2011;30(10):1098-104. doi: 10.1097/ICO.0b013e318206caee.
  106. Swartz M, Jampol LM. Comma-shaped venular segments of conjunctiva in chronic granulocytic leukaemia. Can J Ophthalmol. 1975;10:458-61.
  107. Swartz M, Schumann GB. Acute leukaemic infiltration of the vitreous diagnosed by pars plana aspiration. Am J Ophthalmol. 1980;90:326-30. doi: 10.1016/S0002-9394(14)74911-6.
  108. Vanathi M, Kashyap S, Khan R, et al.Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients. Eur J Ophthalmol. 2014;24(5):655-66. doi: 10.5301/ejo.5000451.
  109. Walton RC, Reed KL. Herpes zoster ophthalmicus following bone marrow transplantation in children. Bone Marrow Transplant. 1999;23:1317-20. doi: 10.1038/sj.bmt.1701796.
  110. Webster AR, Anderson JR, Richard EM, Moore AT. Ischaemic retinopathy occurring in patients receiving bone marrow allografts and campath-1G: a clinicopathological study. Br J Ophthalmol. 1995;79:687-91. doi: 10.1136/bjo.79.7.687.
  111. Willman CL. Acute leukemias: a paradigm for the integration of new technologies in diagnosis and classification. Mod Pathol. 1999;12:218-28.
  112. Wolintz AH, Goldstein JH, Seligman BR, et al. Secondary glaucoma in leukaemia. Ann Ophthalmol. 1971;3:1211-3.
  113. Wu MM, Yau GS, Lee JW, et al. Retrospective review on the use of topical cyclosporin a 0.05 % for paediatric allergic conjunctivitis in Hong Kong Chinese. Scientific World Journal. 2014;396987. doi: 10.1155/2014/396987.
  114. Yaghouti F, Nouri M, Mannor GE. Ocular adnexal granulocytic sarcoma as the first sign of acute myelogenous leukaemia relapse. Am J Ophthalmol. 1999;127:361-3. doi: 10.1016/S0002-9394(98)00363-8.
  115. Yoken J, Forbes B, Maguire AM, et al. Microsporidial endophthalmitis in a patient with acute myelogenous leukaemia. Retina. 2002;22:123-5. doi: 10.1097/00006982-200202000-00028.
  116. Zhioua R, Boussen I, Malek I, Ouertani A. Acute lymphoblastic leukaemia and vitreous infiltration. A case study. J Francais Ophtalmol. 2001;24:180-2.
  117. Zimmerman LE, Thoreson HT. Sudden loss of vision in acute leukaemia. A clinico-pathological report of two unusual cases. Surv Ophthalmol. 1964;9:467-73.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Chistyakova N.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-65574 от 04 мая 2016 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies